Literature DB >> 19208772

Systemic inflammation, metabolic syndrome and progressive renal disease.

Pietro Cirillo, Yuri Y Sautin, John Kanellis, Duk-Hee Kang, Loreto Gesualdo, Takahiko Nakagawa, Richard J Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19208772      PMCID： PMC2721462          DOI： 10.1093/ndt/gfp038

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  46 in total

1.  Adolescents' eating patterns influence their nutrient intakes.

Authors:  J T Dwyer; M Evans; E J Stone; H A Feldman; L Lytle; D Hoelscher; C Johnson; M Zive; M Yang
Journal:  J Am Diet Assoc       Date:  2001-07

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.

Authors:  L Patrick; M Uzick
Journal:  Altern Med Rev       Date:  2001-06

4.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist.

Authors:  Bhavya Voleti; Alok Agrawal
Journal:  Mol Immunol       Date:  2005-07-28       Impact factor: 4.407

6.  Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death.

Authors:  Christine M Albert; Jing Ma; Nader Rifai; Meir J Stampfer; Paul M Ridker
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

7.  A role for uric acid in the progression of renal disease.

Authors:  Duk-Hee Kang; Takahiko Nakagawa; Lili Feng; Susumu Watanabe; Lin Han; Marilda Mazzali; Luan Truong; Raymond Harris; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

8.  Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

Authors:  John Kanellis; Susumu Watanabe; Jin H Li; Duk Hee Kang; Ping Li; Takahiko Nakagawa; Ann Wamsley; David Sheikh-Hamad; Hui Y Lan; Lili Feng; Richard J Johnson
Journal:  Hypertension       Date:  2003-05-12       Impact factor: 10.190

9.  Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.

Authors:  Mario Di Napoli; Francesca Papa
Journal:  Stroke       Date:  2003-11-06       Impact factor: 7.914

Review 10.  Fructose, weight gain, and the insulin resistance syndrome.

Authors:  Sharon S Elliott; Nancy L Keim; Judith S Stern; Karen Teff; Peter J Havel
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045
View more
  18 in total

1.  Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis.

Authors:  Neil H Bhayani; Omar Hyder; Wayne Frederick; Richard D Schulick; Christopher L Wolgang; Kenzo Hirose; Barish Edil; Joseph M Herman; Michael A Choti; Timothy M Pawlik
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

2.  Post-ischemic azotemia as a partial 'brake', slowing progressive kidney disease.

Authors:  Richard A Zager; Ali C Johnson; Kirsten Becker
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

Review 3.  Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease.

Authors:  Annunziata Nancy Crupi; Jonathan Haase; Sebastian Brandhorst; Valter D Longo
Journal:  Curr Diab Rep       Date:  2020-12-10       Impact factor: 4.810

4.  Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

Authors:  Manal F Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; Richard J Johnson; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

5.  Soft drinks consumption and nonalcoholic fatty liver disease.

Authors:  William Nseir; Fares Nassar; Nimer Assy
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

Review 6.  Dietary fats and health: dietary recommendations in the context of scientific evidence.

Authors:  Glen D Lawrence
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

7.  Role of the immune system in hypertension: modulation by dietary antioxidants.

Authors:  Sudesh Vasdev; Jennifer Stuckless; Vernon Richardson
Journal:  Int J Angiol       Date:  2011-12

8.  Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.

Authors:  Richard A Zager; Ali C M Johnson; Steve Lund
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-05

9.  Effects of acute exercise on markers of inflammation in pediatric chronic kidney disease: a pilot study.

Authors:  Keith K Lau; Joyce Obeid; Peter Breithaupt; Vladimir Belostotsky; Steven Arora; Thanh Nguyen; Brian W Timmons
Journal:  Pediatr Nephrol       Date:  2014-10-10       Impact factor: 3.714

10.  Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.

Authors:  Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel
Journal:  Nutr Metab (Lond)       Date:  2012-07-24       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.